title: Controlled oxygen reperfusion protects the lung against early ischemia-reperfusion injury in cardiopulmonary bypasses by downregulating high mobility group box 1.
abstract: Restricting oxygen delivery during the reperfusion phase of cardiopulmonary bypass (CPB) protects the heart, but effects on lung ischemia reperfusion (IR) in CPB are unknown. We examined whether extracellular high mobility group box 1 (HMGB1) mediated inflammation during early lung IR injury in CPB. Fourteen healthy canines received CPB with 60 minutes of aortic clamping and cardioplegic arrest, followed by 90 minutes reperfusion. Following surgery, the animals were randomized into control (n = 7) or test (n = 7) groups. Control animals received a constant level of 80% FiO(2) during the entire procedure, and the test group received a gradual increase in FiO(2) during the first 25 minutes of reperfusion. In the test group, the FiO(2) was initiated at 40% and increased by 10% every 5 minutes, to 80%. Histology, lung injury variables, HMGB1 expression, and inflammatory responses were assessed at baseline (T1) and at 25 minutes (T2) and 90 minutes (T3) after starting reperfusion. Treatment with controlled oxygen significantly suppressed lung pathologies, lung injury variables, and inflammatory responses (all P < .001). After lung IR injury, HMGB1 mRNA and protein expressions were significantly decreased in the controlled oxygen group (all P < .001). Controlled oxygen reperfusion is protective in the early stages of lung IR injury in a canine CPB model, and this protection is linked to HMGB1 downregulation.
authors.affiliation: 1Department of Anesthesiology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
authors.forename: Jian
authors.initials: J
authors.lastname: Rong
authors.forename: Sheng
authors.initials: S
authors.lastname: Ye
authors.forename: Zhong-Kai
authors.initials: ZK
authors.lastname: Wu
authors.forename: Guang-Xian
authors.initials: GX
authors.lastname: Chen
authors.forename: Meng-Ya
authors.initials: MY
authors.lastname: Liang
authors.forename: Hai
authors.initials: H
authors.lastname: Liu
authors.forename: Jin-Xin
authors.initials: JX
authors.lastname: Zhang
authors.forename: Wei-Ming
authors.initials: WM
authors.lastname: Huang
mesh_terms: D055371:Acute Lung Injury / Q000209:etiology / Q000235:genetics / Q000378:metabolism / Q000517:prevention & control*; D000818:Animals; D001483:Base Sequence; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D016207:Cytokines / Q000097:blood; D004195:Disease Models, Animal; D004285:Dogs; D015536:Down-Regulation / Q000187:drug effects; D005260:Female; D024243:HMGB1 Protein / Q000235:genetics* / Q000378:metabolism*; D008168:Lung / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D010100:Oxygen / Q000008:administration & dosage*; D009195:Peroxidase / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D015427:Reperfusion Injury / Q000209:etiology / Q000235:genetics / Q000378:metabolism / Q000517:prevention & control*
chemical_list: D016207:Cytokines; D024243:HMGB1 Protein; D012333:RNA, Messenger; D008315:Malondialdehyde; D009195:Peroxidase; D010100:Oxygen